Patent · US Active

Hereditary cancer genes

US12410478B2 · kind B2 · utility

0Cited by
17References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 22, 2021
Grant dateSep 9, 2025
Priority date
Expiry dateSep 25, 2041

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG16B30/10
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The invention generally relates to a molecular classification of disease predisposition and particularly to molecular markers for cancer predisposition and methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.